‹ All Posts
Dhwani Patel

13th Sep · SEBI-Registered Analyst

MEDANTA
- more downside despite pharma leads

1 - Despite the strength in some of the Pharma stocks hospital stocks are being beaten in last few days 2 -

MEDANTA
is at a critical multi year resistance 3 - it hasnt been able to breach this and now we expect further correction of 105 towards 1150

#TechnicalViews#Post-ClosingCommentary#TimeToExit#PsychologyofMoney
Screenshot 2025-09-13 161254.png
602 likes·48 comments